{"id":"8e087af4-e171-5050-8a00-d41a0b1cdf63","stable_key":"a9dd23c6-978a-5755-8bd8-f29bd1fe0cda:b3-pre-nadsyn-amidation","predicate":"catalyzes-production-of","statement":"Purified human NADSYN1 catalyzed ATP-dependent NAD+ production from nicotinic acid adenine dinucleotide in glutamine-supported assays.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"4a7244b6-b97b-5c44-878a-b78638ddb24e","mechanism_event_label":"The deamidated route finishes by making NAD+ through NADSYN1.","subject":{"id":"66894730-4346-5de1-9315-89e683b122e6","slug":"nadsyn1","display_name":"Human glutamine-dependent NAD synthetase / NADSYN1","entity_type_key":"protein"},"object":{"id":"283ed24b-06a1-50aa-9281-df3bac6ce37e","slug":"nad-plus","display_name":"NAD+","entity_type_key":"small_molecule"},"evidence_count":1,"mechanism_event":{"id":"4a7244b6-b97b-5c44-878a-b78638ddb24e","stable_key":"a9dd23c6-978a-5755-8bd8-f29bd1fe0cda:b3-pre-nadsyn-amidation-event","event_type":"biochemical_relationship","label":"The deamidated route finishes by making NAD+ through NADSYN1.","description":"Purified human NADSYN1 catalyzed ATP-dependent NAD+ production from nicotinic acid adenine dinucleotide in glutamine-supported assays.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"66894730-4346-5de1-9315-89e683b122e6","slug":"nadsyn1","display_name":"Human glutamine-dependent NAD synthetase / NADSYN1","entity_type_key":"protein"},"role":"enzyme","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"4be03515-1913-50d7-a676-dbbb49a0809d","slug":"nicotinic-acid-adenine-dinucleotide","display_name":"Nicotinic acid adenine dinucleotide","entity_type_key":"small_molecule"},"role":"substrate","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"58b974f1-d389-5bf6-81cd-889c44442c42","slug":"atp","display_name":"ATP","entity_type_key":"small_molecule"},"role":"substrate","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"8637bb39-2c30-5168-baaf-3e613d831db0","slug":"glutamine","display_name":"L-Glutamine","entity_type_key":"small_molecule"},"role":"nitrogen donor","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"283ed24b-06a1-50aa-9281-df3bac6ce37e","slug":"nad-plus","display_name":"NAD+","entity_type_key":"small_molecule"},"role":"product","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""}]},"contexts":[{"dimension":"cross_nutrient","value_text":"Glutamine supplies nitrogen for the final amidation of the nicotinic-acid/de novo NAD pathway.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/niacin-precursors-sources/nadsyn2019.paragraphs.txt\", \"locator\": \"Normalized full-text paragraphs 8–8 (0-based)\", \"start_char\": 7090, \"end_char\": 8684, \"file_sha256\": \"36ad82ce734c8e0c44d01c7dc813b1641708738319b53a926e429155b1a602f4\", \"text_sha256\": \"90cb4d2ce3001f2ecf18f1d751db36047726b71a75be94b073474f6f518c96cd\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Recombinant human NADSYN1 steady-state kinetic assays and crystallography; bacterial comparison kept separate","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Biochemical or structural assay; no dietary intervention","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Purified-enzyme evidence does not establish dietary intake requirements or clinical outcomes.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Niacin research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"niacin","display_name":"Niacin (vitamin B3)","entity_type_key":"nutrient_element"}},{"dimension":"organism","value_text":"Homo sapiens","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The deamidated route finishes by making NAD+ through NADSYN1.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[b3-pre-nadsyn2019] Different ways to transport ammonia in human and Mycobacterium tuberculosis NAD+ synthetases. (2020). https://pubmed.ncbi.nlm.nih.gov/31911602/ DOI: 10.1038/s41467-019-13845-4","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Purified recombinant protein; no intact tissue","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"20e3cb20-3b0e-51b8-9e90-2c51c8d6a3ec","evidence_kind":"source_excerpt","locator":"Lines 328-340","start_line":328,"end_line":340,"excerpt":"### b3-pre-nadsyn-amidation\nPurified human NADSYN1 catalyzed ATP-dependent NAD+ production from nicotinic acid adenine dinucleotide in glutamine-supported assays.\nCondition category: normal\nnutrient_topic: Niacin research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: The deamidated route finishes by making NAD+ through NADSYN1.\norganism: Homo sapiens\ntissue_or_cell_type: Purified recombinant protein; no intact tissue\nexperimental_model: Recombinant human NADSYN1 steady-state kinetic assays and crystallography; bacterial comparison kept separate\nlimitations: Purified-enzyme evidence does not establish dietary intake requirements or clinical outcomes.\nexposure: Biochemical or structural assay; no dietary intervention\ncross_nutrient: Glutamine supplies nitrogen for the final amidation of the nicotinic-acid/de novo NAD pathway.\nevidence_span: {\"source_cache\": \"artifacts/niacin-precursors-sources/nadsyn2019.paragraphs.txt\", \"locator\": \"Normalized full-text paragraphs 8–8 (0-based)\", \"start_char\": 7090, \"end_char\": 8684, \"file_sha256\": \"36ad82ce734c8e0c44d01c7dc813b1641708738319b53a926e429155b1a602f4\", \"text_sha256\": \"90cb4d2ce3001f2ecf18f1d751db36047726b71a75be94b073474f6f518c96cd\"}\n[b3-pre-nadsyn2019] Different ways to transport ammonia in human and Mycobacterium tuberculosis NAD+ synthetases. (2020). https://pubmed.ncbi.nlm.nih.gov/31911602/ DOI: 10.1038/s41467-019-13845-4","model_system":"Recombinant human NADSYN1 steady-state kinetic assays and crystallography; bacterial comparison kept separate","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [b3-pre-nadsyn2019] Different ways to transport ammonia in human and Mycobacterium tuberculosis NAD+ synthetases. (2020). https://pubmed.ncbi.nlm.nih.gov/31911602/ DOI: 10.1038/s41467-019-13845-4","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"a62b7b5b-786a-57e9-85e9-67c6912a5054","stable_key":"import-a9dd23c6-978a-5755-8bd8-f29bd1fe0cda","title":"Niacin: NAD metabolism, deficiency and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"a8cac59639322f74812ce12eef338c2f6c385c04cc4af6ab511fc7c972f0c2e6","revision_id":"bec8fc45-12e7-5f75-a814-5d72ed015d01","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}